Hemostasis Today
NewsFeed
Headlines Hematology Health Medicine VTE ASH Plasma Donation
March, 2026
March 2026
M T W T F S S
 1
2345678
9101112131415
16171819202122
23242526272829
3031  
Colleen Silk on Novo Nordisk Performance at ASH25
Colleen Silk/LinkedIn
Dec 14, 2025, 15:07

Colleen Silk on Novo Nordisk Performance at ASH25

Colleen Silk, Corporate Vice President, Rare Disease at Novo Nordisk, shared on LinkedIn:

”I’m so proud to have attended the 2025 ASH Annual Meeting in Orlando over the weekend alongside so many talented colleagues from our Hemoglobinopathies and Rare Blood Disorders teams.

It was so inspiring to see the dedication, expertise, and collaboration that went into making this meeting such a success for Novo Nordisk.

In addition to the great work that went into our exhibit booth and many poster and oral presentations, ASH was an invaluable opportunity to engage directly with the hematology community.

We had meaningful conversations with KOLs where we shared the science and our vision for expanding treatment options for people living with rare blood disorders and sickle cell disease.

These dialogues will help shape our path forward and accelerate the impact of our future portfolio.

A huge thank you to everyone who worked so hard to bring this to life.

From our US Field and Home Office cross-functional teams and our partners in Global, everyone contributed to making the congress truly outstanding.

I’m excited for what lies ahead for the Rare Disease team at Novo Nordisk as we continue to educate with the goal of bringing innovative therapies to patients who need them most.”

Colleen Silk on Novo Nordisk Performance at ASH25

Stay updated with Hemostasis Today.

ASH2025 ASH25 Colleen Silk Health Hematology Hemoglobinopathies Hemostasis Hemostasis Today Medicine Novo Nordisk SCD Sickle Cell Disease thrombosis
NewsFeed